Occidental Petroleum Eyes $10 Billion OxyChem Sale Amid Debt Reduction Drive

Occidental Petroleum (NYSE: OXY) is reportedly in advanced talks to sell its chemical business, OxyChem, in a transaction valued at around $10 billion, according to the Financial Times. The deal, expected to be announced in the coming weeks, would mark the oil giant’s largest divestiture to date as it works to reduce its significant debt burden.

The move aligns with Occidental’s ongoing strategy of asset sales to strengthen its balance sheet after years of aggressive acquisitions. In 2019, the company made headlines with its $55 billion takeover of Anadarko Petroleum, a deal that left it with substantial debt. More recently, in 2023, Occidental spent $13 billion acquiring shale producer CrownRock, further adding to its financial obligations. With oil prices under prolonged pressure, the company has doubled down on divestments to manage liabilities and maintain cash flow.

OxyChem, which produces essential chemicals used across industries, has been a valuable subsidiary for Occidental. However, selling the unit could provide a much-needed capital boost, allowing the company to accelerate debt repayment and improve its financial flexibility. Analysts note that this sale could be pivotal for Occidental, as it looks to balance shareholder returns with long-term financial stability.

Over the past several years, Occidental has executed a string of smaller divestitures, including the sale of four development assets in the Permian Basin in August. The anticipated OxyChem deal, however, would far surpass those transactions in scale and impact, underscoring the company’s commitment to deleveraging.

As energy markets remain volatile, investors and industry watchers will be closely monitoring the outcome of the OxyChem sale. If successful, the divestiture could reshape Occidental’s portfolio while signaling a renewed focus on its core oil and gas operations.